Literature DB >> 26032847

Betulinic Acid and its Derivatives as Potential Antitumor Agents.

Dong-Mei Zhang1, Hong-Gui Xu2, Lei Wang1, Ying-Jie Li1, Ping-Hua Sun2, Xiao-Ming Wu3, Guang-Ji Wang3, Wei-Min Chen2, Wen-Cai Ye1.   

Abstract

Betulinic acid (BA) is a lupane-type pentacyclic triterpene, distributed ubiquitously throughout the plant kingdom. BA and its derivatives demonstrate multiple bioactivities, particularly an antitumor effect. This review critically describes the recent research on isolation, synthesis, and derivatization of BA and its natural analogs betulin and 23-hydroxybetulinic acid. The subsequent part of the review focuses on the current knowledge of antitumor properties, combination treatments, and pharmacological mechanisms of these compounds. A 3D-QSAR analysis of 62 BA derivatives against human ovarian cancer A2780 is also included to provide information concerning the structure-cytotoxicity relationships of these compounds.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  antitumor effect; betulinic acid; derivatives; structure-cytotoxicity relationship

Mesh:

Substances:

Year:  2015        PMID: 26032847     DOI: 10.1002/med.21353

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  25 in total

1.  Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.

Authors:  Ran Tao; Chengzhang Wang; Yin Lu; Changwei Zhang; Hao Zhou; Hongxia Chen; WenJun Li
Journal:  Int J Nanomedicine       Date:  2020-04-22

2.  A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells.

Authors:  Nan Yao; Ying-Jie Li; Yu-He Lei; Nan Hu; Wei-Min Chen; Zhe Yao; Miao Yu; Jun-Shan Liu; Wen-Cai Ye; Dong-Mei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-12-08

3.  Betulinic acid‑induced expression of nicotinamide adenine dinucleotide phosphate‑diaphorase in the immune organs of mice: A possible role of nitric oxide in immunomodulation.

Authors:  Kai Le Pang; Kavitha Vijayaraghavan; Badr Al Sayed; Mohamed Ali Seyed
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

4.  Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.

Authors:  Huidi Liu; Zheng Zeng; Siwen Wang; Ting Li; Emilio Mastriani; Qing-Hai Li; Hong-Xia Bao; Yu-Jie Zhou; Xiaoyu Wang; Yongfang Liu; Wei Liu; Sijing Hu; Shan Gao; Miao Yu; Yingying Qi; Zhihang Shen; Hongyue Wang; Tingting Gao; Lingqin Dong; Randal N Johnston; Shu-Lin Liu
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

Review 5.  Terpenoids' anti-cancer effects: focus on autophagy.

Authors:  Chirine El-Baba; Amro Baassiri; Georges Kiriako; Batoul Dia; Sukayna Fadlallah; Sara Moodad; Nadine Darwiche
Journal:  Apoptosis       Date:  2021-07-16       Impact factor: 4.677

Review 6.  Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria.

Authors:  Anna Yu Spivak; Darya A Nedopekina; Rinat R Gubaidullin; Mikhail V Dubinin; Konstantin N Belosludtsev
Journal:  J Pers Med       Date:  2021-05-25

7.  Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non-small-Cell Lung Cancer In Vivo and In Vitro.

Authors:  Chao-Yue Sun; Di Cao; Qian-Nan Ren; Shan-Shan Zhang; Ning-Ning Zhou; Shi-Juan Mai; Bing Feng; Hui-Yun Wang
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

8.  Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate.

Authors:  Laiyin Zhang; Shuangxing Hou; Bo Li; Jianjian Pan; Liping Jiang; Guiying Zhou; Hong Gu; Caixing Zhao; Huiping Lu; Fenfen Ma
Journal:  Onco Targets Ther       Date:  2018-01-15       Impact factor: 4.147

Review 9.  Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.

Authors:  Ana M L Seca; Diana C G A Pinto
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923

10.  Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Authors:  Gloria Brusotti; Roberta Montanari; Davide Capelli; Giulia Cattaneo; Antonio Laghezza; Paolo Tortorella; Fulvio Loiodice; Franck Peiretti; Bernadette Bonardo; Alessandro Paiardini; Enrica Calleri; Giorgio Pochetti
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.